APEX1 and primitive neuroectodermal tumor: An analysis of APE1 activity in medulloblastomas and neuroectodermal tumors from patients treated with adjuvant radiation and multi-agent chemotherapy, found that increased APE1 activity correlated with poorer response to treatment (78).